128 related articles for article (PubMed ID: 10741951)
1. A canine model of multiple portosystemic shunting.
Howe LM; Boothe HW; Miller MW; Boothe DM
J Invest Surg; 2000; 13(1):45-57. PubMed ID: 10741951
[TBL] [Abstract][Full Text] [Related]
2. Endotoxemia associated with experimentally induced multiple portosystemic shunts in dogs.
Howe LM; Boothe DM; Boothe HW
Am J Vet Res; 1997 Jan; 58(1):83-8. PubMed ID: 8989502
[TBL] [Abstract][Full Text] [Related]
3. Effects of vena caval banding in experimentally induced multiple portosystemic shunts in dogs.
Butler-Howe LM; Boothe HW; Boothe DM; Laine GA; Calvin JA
Am J Vet Res; 1993 Oct; 54(10):1774-83. PubMed ID: 8250407
[TBL] [Abstract][Full Text] [Related]
4. Detection of portal and systemic bacteremia in dogs with severe induced hepatic disease and multiple portosystemic shunts.
Howe LM; Boothe DM; Boothe HW
Am J Vet Res; 1999 Feb; 60(2):181-5. PubMed ID: 10048548
[TBL] [Abstract][Full Text] [Related]
5. Ultrasonography, biochemical and hematological profiles in liver disease caused by intravenous administration of dimethylnitrosamine in dogs.
Mwanza T; Miyamoto T; Okumura M; Kadosawa T; Fujinaga T
Jpn J Vet Res; 1997 Nov; 45(3):153-61. PubMed ID: 9433016
[TBL] [Abstract][Full Text] [Related]
6. Relationship between (99m)Tc-GSA scintigraphic indices of liver function reserve and portal circulation in patients with chronic liver disease.
Osada H; Honda N; Takahashi T; Oku S; Abe A; Watanabe W; Okada T; Ohno H; Hondo M; Nishimura K
Ann Nucl Med; 2007 Jul; 21(5):245-9. PubMed ID: 17634841
[TBL] [Abstract][Full Text] [Related]
7. Effects of total and selective portasystemic shunting on hepatic haemodynamics and some aspects of liver function in the cirrhotic rat.
Jenkins SA; Baxter JN; Devitt P; Shields R
Clin Exp Pharmacol Physiol; 1986 Sep; 13(9):671-80. PubMed ID: 3802582
[TBL] [Abstract][Full Text] [Related]
8. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
Conn HO; Rössle M; Levy L; Glocker FX
Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
[TBL] [Abstract][Full Text] [Related]
9. Dimethylnitrosamine-induced hepatotoxicosis in dogs as a model of progressive canine hepatic disease.
Boothe DM; Jenkins WL; Green RA; Corrier DE; Cullen JM; Boothe HW; Weise D
Am J Vet Res; 1992 Mar; 53(3):411-20. PubMed ID: 1595969
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characteristics of hepatic lipogranulomas with portosystemic shunt in dogs.
Isobe K; Matsunaga S; Nakayama H; Uetsuka K
J Vet Med Sci; 2008 Feb; 70(2):133-8. PubMed ID: 18319572
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.
Van den Bossche L; Schoonenberg VAC; Burgener IA; Penning LC; Schrall IM; Kruitwagen HS; van Wolferen ME; Grinwis GCM; Kummeling A; Rothuizen J; van Velzen JF; Stathonikos N; Molenaar MR; Helms BJ; Brouwers JFHM; Spee B; van Steenbeek FG
PLoS One; 2017; 12(10):e0186491. PubMed ID: 29049355
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a portocaval venograft and ameroid ring for the occlusion of intrahepatic portocaval shunts in dogs.
Kyles AE; Gregory CR; Jackson J; Ilkiw JE; Pascoe PJ; Adin C; Samii VF; Herrgesell E
Vet Surg; 2001; 30(2):161-9. PubMed ID: 11230770
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ultrasonographic findings with surgical, portographic, and necropsy findings in dogs and cats with portosystemic shunts: 63 cases (1987-1993).
Holt DE; Schelling CG; Saunders HM; Orsher RJ
J Am Vet Med Assoc; 1995 Nov; 207(9):1190-3. PubMed ID: 7559068
[TBL] [Abstract][Full Text] [Related]
14. Hepatic lesions of a standard poodle dog with intrahepatic portosystemic shunt.
Isobe K; Matsunaga S; Nakayama H; Uetsuka K
J Vet Med Sci; 2008 Oct; 70(10):1125-8. PubMed ID: 18981673
[TBL] [Abstract][Full Text] [Related]
15. Multiple congenital PSS in a dog: case report and literature review.
Leeman JJ; Kim SE; Reese DJ; Risselada M; Ellison GW
J Am Anim Hosp Assoc; 2013; 49(4):281-5. PubMed ID: 23690491
[TBL] [Abstract][Full Text] [Related]
16. Correlation between liver volume, portal vascular anatomy, and hepatic perfusion in dogs with congenital portosystemic shunt before and after placement of ameroid constrictors.
Zwingenberger AL; Daniel L; Steffey MA; Mayhew PD; Mayhew KN; Culp WT; Hunt GB
Vet Surg; 2014 Nov; 43(8):926-34. PubMed ID: 24724740
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic diagnosis of portosystemic shunting in dogs and cats.
d'Anjou MA; Penninck D; Cornejo L; Pibarot P
Vet Radiol Ultrasound; 2004; 45(5):424-37. PubMed ID: 15487568
[TBL] [Abstract][Full Text] [Related]
18. Dimethylnitrosamine-induced hepatic cirrhosis: a new canine model of an ancient human disease.
Madden JW; Gertman PM; Peacock EE
Surgery; 1970 Jul; 68(1):260-7; discussion 267-8. PubMed ID: 10483478
[TBL] [Abstract][Full Text] [Related]
19. Portal-Systemic shunts reduce asialoglycoprotein receptor density in rats.
Colquhoun SD; Connelly CA; Vera DR
J Nucl Med; 2001 Jan; 42(1):110-6. PubMed ID: 11197958
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of congenital portosystemic shunt reduces inflammation in dogs.
Tivers MS; Handel I; Gow AG; Lipscomb VJ; Jalan R; Mellanby RJ
PLoS One; 2015; 10(2):e0117557. PubMed ID: 25658922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
